Testis-expressed gene 11 inhibits cisplatin-induced DNA damage and contributes to chemoresistance in testicular germ cell tumor
- PMID: 36319719
- PMCID: PMC9626550
- DOI: 10.1038/s41598-022-21856-3
Testis-expressed gene 11 inhibits cisplatin-induced DNA damage and contributes to chemoresistance in testicular germ cell tumor
Abstract
Testicular germ cell tumor (TGCT) is a rare cancer but the most common tumor among adolescent and young adult males. Patients with advanced TGCT often exhibit a worse prognosis due to the acquisition of therapeutic resistance. Cisplatin-based chemotherapy is a standard treatment for advanced TGCTs initially sensitive to cisplatin, as exemplified by embryonal carcinoma. The acquisition of cisplatin resistance, however, could be a fatal obstacle for TGCT management. To identify cisplatin resistance-related genes, we performed transcriptome analysis for cisplatin-resistant TGCT cells compared to parental cells. In two types of cisplatin-resistant TGCT cell models that we established from patient-derived TGCT cells, and from the NEC8 cell line, we found that mRNA levels of the high-mobility-group nucleosome-binding gene HMGN5 and meiosis-related gene TEX11 were remarkably upregulated compared to those in the corresponding parental cells. We showed that either HMGN5 or TEX11 knockdown substantially reduced the viability of cisplatin-resistant TGCT cells in the presence of cisplatin. Notably, TEX11 silencing in cisplatin-resistant TGCT cells increased the level of cleaved PARP1 protein, and the percentage of double-strand break marker γH2AX-positive cells. We further demonstrated the therapeutic efficiency of TEX11-specific siRNA on in vivo xenograft models derived from cisplatin-resistant patient-derived TGCT cells. Taken together, the present study provides a potential insight into a mechanism of cisplatin resistance via TEX11-dependent pathways that inhibit apoptosis and DNA damage. We expect that our findings can be applied to the improvement of cisplatin-based chemotherapy for TGCT, particularly for TEX11-overexpressing tumor.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9626550/bin/41598_2022_21856_Fig1_HTML.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9626550/bin/41598_2022_21856_Fig2_HTML.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9626550/bin/41598_2022_21856_Fig3_HTML.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9626550/bin/41598_2022_21856_Fig4_HTML.gif)
Similar articles
-
Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to Cisplatin and poly (adp-ribose) polymerase inhibition.PLoS One. 2012;7(12):e51563. doi: 10.1371/journal.pone.0051563. Epub 2012 Dec 12. PLoS One. 2012. PMID: 23251575 Free PMC article.
-
Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer.Br J Cancer. 2012 Nov 20;107(11):1853-63. doi: 10.1038/bjc.2012.481. Br J Cancer. 2012. PMID: 23169338 Free PMC article.
-
Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.Cell Oncol (Dordr). 2017 Aug;40(4):341-355. doi: 10.1007/s13402-017-0326-8. Epub 2017 May 23. Cell Oncol (Dordr). 2017. PMID: 28536927
-
Testicular germ cell tumours: the paradigm of chemo-sensitive solid tumours.Int J Biochem Cell Biol. 2005 Dec;37(12):2437-56. doi: 10.1016/j.biocel.2005.06.014. Epub 2005 Aug 11. Int J Biochem Cell Biol. 2005. PMID: 16099193 Review.
-
Testicular germ cell tumor genomics.Curr Opin Urol. 2017 Jan;27(1):41-47. doi: 10.1097/MOU.0000000000000347. Curr Opin Urol. 2017. PMID: 27584029 Free PMC article. Review.
Cited by
-
Molecular profiling and specific targeting of gemcitabine-resistant subclones in heterogeneous pancreatic cancer cell populations.Front Oncol. 2023 Aug 31;13:1230382. doi: 10.3389/fonc.2023.1230382. eCollection 2023. Front Oncol. 2023. PMID: 37719017 Free PMC article.
-
BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis.Cancer Med. 2023 Jul;12(14):15650-15663. doi: 10.1002/cam4.6167. Epub 2023 Jun 9. Cancer Med. 2023. PMID: 37293953 Free PMC article.
-
Breaking the Mold: Epigenetics and Genomics Approaches Addressing Novel Treatments and Chemoresponse in TGCT Patients.Int J Mol Sci. 2023 Apr 26;24(9):7873. doi: 10.3390/ijms24097873. Int J Mol Sci. 2023. PMID: 37175579 Free PMC article. Review.
-
Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options.Mol Med. 2023 Mar 29;29(1):40. doi: 10.1186/s10020-023-00636-3. Mol Med. 2023. PMID: 36991316 Free PMC article.
References
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous